News
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.
How a new Trump plan could make science ‘a political football’ The NIH is already in turmoil. Billlions of dol ...
Trump administration proposal is seen as a way to make NIH institute and center directors political appointees.
People often think that they will be perfectly fine with just one kidney. But there are long-term health consequences, and ...
In its flagship journal, the CDC keeps publishing papers after firing scientists who made the research possible.
A Merus drug, combined with Keytruda, shows preliminary survival gains in newly diagnosed metastatic head and neck cancer ...
As Hinge Health goes public, CEO Dan Perez tells STAT the goal is to automate physical therapy in any way it can.
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
The MAHA commission's assessment of children's health mirrored RFK Jr.'s familiar targets. The question now is what remedies ...
Point-of-care medication dispensing offers a return to a more straightforward approach, common to physician practices ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results